PAUL BILLINGS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cardiff Oncology, Inc.

Filing Date Source Excerpt
2015-10-16 Paul Billings As of December 31, 2014, 51,230 stock options were outstanding, of which 23,000 were exercisable.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22